SGLT2 inhibitors are preferred in people with HF or at high-risk for HF, whereas GLP-1 receptor agonists are favored for those requiring significant weight loss, ASCVD risk reduction, CKD management, or in whom mitigation of metabolic dysfunction-associated steatotic liver disease (MASLD) or steatohepatitis is a clinical priority [84]
The reality is that no pill can teach you how to meal plan, manage stress without food, or build consistent exercise habits that you actually enjoy
Even if GLP-1s have lower efficacy than an existing treatment (and there are indications that they may have higher efficacy), if they can reach many times more people, the overall public health impact would be massive
Participants receiving the highest dose (12 mg weekly) achieved a mean body weight reduction of approximately 24% over 48 weeks results that exceeded those seen with currently approved agents at the time of publication
Salmonella entry into host cells: the work in concert of type III secreted effector proteins
If you suspect you're not getting enough L-Carnitine, consider consulting with a healthcare provider or a nutritionist